These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 2564231
21. 5-Fluorouracil cytotoxicity in human colon HT-29 cells with moderately increased or decreased cellular glutathione level. Chen MF, Chen LT, Boyce HW. Anticancer Res; 1995; 15(1):163-7. PubMed ID: 7733628 [Abstract] [Full Text] [Related]
22. Glutathione as a determinant of cellular response to doxorubicin. Lee FY, Vessey AR, Siemann DW. NCI Monogr; 1988; (6):211-5. PubMed ID: 3352767 [Abstract] [Full Text] [Related]
27. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C. Xia H, Pinto T, Hu X, Benson PJ, Zaren HA, Gupta V, Singh S. Cancer Res; 1996 Aug 01; 56(15):3495-8. PubMed ID: 8758917 [Abstract] [Full Text] [Related]
28. Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response. Edgren M, Nishidai T, Scott OC, Révész L. Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr 01; 47(4):463-74. PubMed ID: 3872859 [Abstract] [Full Text] [Related]
31. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA, Greene K, Ahmad S, Vistica DT. Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359 [Abstract] [Full Text] [Related]
32. Glutathione contents in human and rodent tumor cells in various phases of the cell cycle. Lee FY, Siemann DW, Allalunis-Turner MJ, Keng PC. Cancer Res; 1988 Jul 01; 48(13):3661-5. PubMed ID: 3378209 [Abstract] [Full Text] [Related]
33. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells. Paranka NS, Dorr RT. Anticancer Res; 1994 Jul 01; 14(5A):2047-52. PubMed ID: 7847848 [Abstract] [Full Text] [Related]
35. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine. Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E. Radiat Res; 1984 May 01; 98(2):370-80. PubMed ID: 6539482 [Abstract] [Full Text] [Related]
36. Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO. Gallo JM, Brennan J, Hamilton TC, Halbherr T, Laub PB, Ozols RF, O'Dwyer PJ. Cancer Res; 1995 Oct 15; 55(20):4507-11. PubMed ID: 7553617 [Abstract] [Full Text] [Related]
37. Inhibition of cell colony formation by selenite: involvement of glutathione. Caffrey PB, Frenkel GD. Mol Pharmacol; 1991 Mar 15; 39(3):281-4. PubMed ID: 1826039 [Abstract] [Full Text] [Related]
38. Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells. Ling CC, Wong RS, Basas RD. Int J Radiat Oncol Biol Phys; 1990 Feb 15; 18(2):325-30. PubMed ID: 2137437 [Abstract] [Full Text] [Related]
39. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS. Cancer Res; 1988 May 15; 48(10):2764-7. PubMed ID: 3359437 [Abstract] [Full Text] [Related]
40. Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle. Matsunaga K, Mashiba H. Eur Cytokine Netw; 1992 May 15; 3(3):307-11. PubMed ID: 1498261 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]